KOD · Kodiak Sciences Inc. · Debt
$108.25
-1.09 (-1.00%)
At close · Nov 12
Return incl. dividend (before tax)
Q4 2023 earnings call transcript
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, we had cash and cash equivalents of $125.9 million. We have incurred net losses and negative cash flows from operations since inception. We expect to continue to incur operating losses and negative operating cash flows for the foreseeable future and as a result, there is substantial doubt regarding our ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$6.80B
Shares
62.85M
Volume · Nov 12
561.2K
Avg daily vol (3M)
1.74M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Read debt and covenant terms in your AI or your code through MCP and the API →Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current operating lease liabilities | 2026-09-30 | USD 5,288,000 | 10-Q filed 2026-11-12 |
| Noncurrent operating lease liabilities | 2026-09-30 | USD 41,276,000 | 10-Q filed 2026-11-12 |
| Other long-term debt | 2026-09-30 | USD 826,000 | 10-Q filed 2026-11-12 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
1468748
CUSIP
50015M109
13F (30d)
118 filings
105 filers
Visit website
Investor relations